Design and Rationale for comParison Between ticagreLor and clopidogrEl on mIcrocirculation in Patients with Acute cOronary Syndrome Undergoing Percutaneous Coronary Intervention (PLEIO) Trial.
김영대, 김무현, 박경일, 조용락, 박종성, 박태호
Journal of Cardiovascular Translational Research, 2018
72
Rosuvastatin inhibits high glucose-stimulated upregulation of VCAM-1 via the MAPK-signalling pathway in endothelial cells.
김무현, Kim, Chae-Eun, Kim, Sung-Whan
Acta Cardiologica, 2018
73
Assessing Vessel Tone during Coronary Artery Spasm by Dual-Acquisition Multidetector Computed Tomography Angiography.
김무현, Jin C.D, Kang E.J, 조용락, 박태호, Lee K.N, Serebruany V
Cardiology, 2018
74
Worldwide reporting of fatal outcomes after ticagrelor to the US Food and Drug
Administration.
김무현, Serebruany VL, Marciniak TA
European Heart Journal, 2018
75
Filing Sources after Oral P(2)Y12 Platelet Inhibitors to the Food and Drug Administration Adverse Event Reporting System (FAERS)
Platelet microRNA for predicting acute myocardial infarction
김무현, Shuhua Li, Long Zhe Guo, Jin-Yeong Han, Victor Serebruany
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2017
77
A Prospective, Randomized, Open-Label, Blinded, Endpoint Study Exploring Platelet Response to Half-Dose Prasugrel and Ticagrelor in Patients with the Acute Coronary Syndrome: HOPE-TAILOR Study.
김무현, Jin C, Bang J, Serebruany V
Cardiology, 2017
78
CRUSADE Score is Superior to Platelet Function Testing for Prediction of Bleeding in Patients Following Coronary Interventions
김무현, Junghee Bang, Sun Young Choi, Victor Serebruany
EBIOMEDICINE, 2017
79
Excess Ticagrelor Mortality in the Food and Drug Administration Adverse Event Reporting System: Time to Recount PLATO Trial Deaths
김무현, Serebruany VL, Fortmann SD, Cherepanov V, Litvinov O, Marciniak TA
AMERICAN JOURNAL OF MEDICINE, 2017
80
Inhibition of Angiotensin II-Induced Cardiac Fibrosis by Atorvastatin in Adiponectin Knockout Mice.
Roh MS, Kim CR, Park JS, Serebruany V, 김무현, Choi SY